- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
L&H CEO steps down, cofounder leaves board
John Duerden has called it quits as CEO of Lernout & Hauspie, although he remains on the board of directors. Philippe Bodson, formerly head of Belgian utility firm Tractebel, has been tapped to fill the vacancy as CEO. Meanwhile, company cofounder Jo
John Duerden has called it quits as CEO of Lernout & Hauspie, although he remains on the board of directors. Philippe Bodson, formerly head of Belgian utility firm Tractebel, has been tapped to fill the vacancy as CEO. Meanwhile, company cofounder Jo Lernout has stepped down from the board, although he will continue as chief technology officer.
In his first six months at the helm of the struggling voice recognition firm, Duerden ventured to Korea in search of $100 million in missing corporate funds and guided the company's first corporate steps toward bankruptcy protection (SCAN, 12/20/00). Now the odyssey is over.
The executive changes are coming just as L&H embarks on a massive restructuring effort as part of its bankruptcy protection plan, which has been granted in both the U.S. and Belgium. The company plans to cut 1200 jobs (about 20% of its workforce), shut down operations in South Korea, and withdraw from the retail market.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
